• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体介导的登革热免疫反应建模:一项定性研究。

Modeling Dengue Immune Responses Mediated by Antibodies: A Qualitative Study.

作者信息

Sebayang Afrina Andriani, Fahlena Hilda, Anam Vizda, Knopoff Damián, Stollenwerk Nico, Aguiar Maíra, Soewono Edy

机构信息

Department of Mathematics, Institut Teknologi Bandung, Bandung 40132, Indonesia.

Basque Centre for Applied Mathematics (BCAM), Alameda Mazarredo, 14, 48009 Bilbao, Spain.

出版信息

Biology (Basel). 2021 Sep 20;10(9):941. doi: 10.3390/biology10090941.

DOI:10.3390/biology10090941
PMID:34571818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8464952/
Abstract

Dengue fever is a viral mosquito-borne infection and a major international public health concern. With 2.5 billion people at risk of acquiring the infection around the world, disease severity is influenced by the immunological status of the individual, seronegative or seropositive, prior to natural infection. Caused by four antigenically related but distinct serotypes, DENV-1 to DENV-4, infection by one serotype confers life-long immunity to that serotype and a period of temporary cross-immunity (TCI) to other serotypes. The clinical response on exposure to a second serotype is complex with the so-called antibody-dependent enhancement (ADE) process, a disease augmentation phenomenon when pre-existing antibodies to previous dengue infection do not neutralize but rather enhance the new infection, used to explain the etiology of severe disease. In this paper, we present a minimalistic mathematical model framework developed to describe qualitatively the dengue immunological response mediated by antibodies. Three models are analyzed and compared: (i) primary dengue infection, (ii) secondary dengue infection with the same (homologous) dengue virus and (iii) secondary dengue infection with a different (heterologous) dengue virus. We explore the features of viral replication, antibody production and infection clearance over time. The model is developed based on body cells and free virus interactions resulting in infected cells activating antibody production. Our mathematical results are qualitatively similar to the ones described in the empiric immunology literature, providing insights into the immunopathogenesis of severe disease. Results presented here are of use for future research directions to evaluate the impact of dengue vaccines.

摘要

登革热是一种由蚊子传播的病毒性感染疾病,也是国际公共卫生领域的重大关切。全球有25亿人面临感染风险,疾病的严重程度受个体在自然感染前的免疫状态(血清阴性或血清阳性)影响。登革热由四种抗原相关但不同的血清型(DENV-1至DENV-4)引起,感染一种血清型可使人对该血清型产生终身免疫,并对其他血清型产生一段时间的临时交叉免疫(TCI)。接触第二种血清型时的临床反应较为复杂,存在所谓的抗体依赖性增强(ADE)过程,即先前登革热感染产生的抗体不能中和反而增强新感染的疾病加重现象,这一过程被用于解释重症疾病的病因。在本文中,我们提出了一个简约的数学模型框架,用于定性描述由抗体介导的登革热免疫反应。分析并比较了三种模型:(i)初次登革热感染,(ii)感染相同(同源)登革热病毒的二次登革热感染,以及(iii)感染不同(异源)登革热病毒的二次登革热感染。我们探究了病毒复制、抗体产生和感染清除随时间的变化特征。该模型基于体细胞与游离病毒的相互作用构建,感染细胞会激活抗体产生。我们的数学结果在定性上与经验免疫学文献中描述的结果相似,为重症疾病的免疫发病机制提供了见解。本文呈现的结果有助于未来评估登革热疫苗影响的研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/87114ca5fa12/biology-10-00941-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/bfd54573f0b1/biology-10-00941-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/967f1d662705/biology-10-00941-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/6b87e6fa6a53/biology-10-00941-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/533e395cbe8a/biology-10-00941-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/e280240a031f/biology-10-00941-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/d34a0f590953/biology-10-00941-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/bc5747adfeaf/biology-10-00941-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/5763d63b880f/biology-10-00941-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/9392f9dbd5a0/biology-10-00941-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/87114ca5fa12/biology-10-00941-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/bfd54573f0b1/biology-10-00941-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/967f1d662705/biology-10-00941-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/6b87e6fa6a53/biology-10-00941-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/533e395cbe8a/biology-10-00941-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/e280240a031f/biology-10-00941-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/d34a0f590953/biology-10-00941-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/bc5747adfeaf/biology-10-00941-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/5763d63b880f/biology-10-00941-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/9392f9dbd5a0/biology-10-00941-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/950d/8464952/87114ca5fa12/biology-10-00941-g010.jpg

相似文献

1
Modeling Dengue Immune Responses Mediated by Antibodies: A Qualitative Study.抗体介导的登革热免疫反应建模:一项定性研究。
Biology (Basel). 2021 Sep 20;10(9):941. doi: 10.3390/biology10090941.
2
Mathematical models for dengue fever epidemiology: A 10-year systematic review.登革热流行病学的数学模型:一项 10 年系统性回顾。
Phys Life Rev. 2022 Mar;40:65-92. doi: 10.1016/j.plrev.2022.02.001. Epub 2022 Feb 15.
3
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.抗体依赖增强作用:开发安全登革热疫苗的挑战。
Front Cell Infect Microbiol. 2020 Oct 22;10:572681. doi: 10.3389/fcimb.2020.572681. eCollection 2020.
4
Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.绘制人类记忆B细胞和血清中和抗体对登革病毒4型感染及疫苗接种的反应图谱。
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.02041-16. Print 2017 Mar 1.
5
Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.工程化登革病毒结构域 III 蛋白在小鼠中引发交叉中和抗体反应。
J Virol. 2018 Aug 29;92(18). doi: 10.1128/JVI.01023-18. Print 2018 Sep 15.
6
Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection.抗体依赖性登革病毒进入调节细胞固有反应增强感染。
mSphere. 2019 Sep 18;4(5):e00528-19. doi: 10.1128/mSphere.00528-19.
7
Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.登革热病毒中和及抗体依赖增强活性的人源单克隆抗体来源于二次感染急性期的登革热患者。
Antiviral Res. 2013 Jun;98(3):423-31. doi: 10.1016/j.antiviral.2013.03.018. Epub 2013 Mar 29.
8
Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection.固有 ADE:登革热感染期间抗体依赖增强的阴暗面。
Front Cell Infect Microbiol. 2020 Oct 2;10:580096. doi: 10.3389/fcimb.2020.580096. eCollection 2020.
9
Dissecting the human serum antibody response to secondary dengue virus infections.剖析人类血清对登革病毒二次感染的抗体反应。
PLoS Negl Trop Dis. 2017 May 15;11(5):e0005554. doi: 10.1371/journal.pntd.0005554. eCollection 2017 May.
10
The effect of antibody-dependent enhancement, cross immunity, and vector population on the dynamics of dengue fever.抗体依赖性增强、交叉免疫和媒介种群对登革热动态的影响。
J Theor Biol. 2013 Feb 21;319:62-74. doi: 10.1016/j.jtbi.2012.11.021. Epub 2012 Dec 1.

引用本文的文献

1
Exploiting host kinases to combat dengue virus infection and disease.利用宿主激酶对抗登革病毒感染及疾病。
Antiviral Res. 2025 May 8;241:106172. doi: 10.1016/j.antiviral.2025.106172.
2
Clinical and Laboratory Features and Treatment Outcomes of Dengue Fever in Pediatric Cases.小儿登革热的临床和实验室特征及治疗结果
Cureus. 2024 Dec 16;16(12):e75840. doi: 10.7759/cureus.75840. eCollection 2024 Dec.
3
The Mathematical Modeling of the Host-Virus Interaction in Dengue Virus Infection: A Quantitative Study.登革病毒感染中宿主-病毒相互作用的数学建模:定量研究。

本文引用的文献

1
Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003).定义由减毒四价登革热疫苗(TAK-003)诱导的登革病毒血清型特异性中和抗体水平。
PLoS Negl Trop Dis. 2021 Mar 12;15(3):e0009258. doi: 10.1371/journal.pntd.0009258. eCollection 2021 Mar.
2
The Impact of Serotype Cross-Protection on Vaccine Trials: DENVax as a Case Study.血清型交叉保护对疫苗试验的影响:以DENVax为例
Vaccines (Basel). 2020 Nov 12;8(4):674. doi: 10.3390/vaccines8040674.
3
The role of IgG Fc receptors in antibody-dependent enhancement.
Viruses. 2024 Jan 31;16(2):216. doi: 10.3390/v16020216.
4
Within-host models unravelling the dynamics of dengue reinfections.揭示登革热再感染动态的宿主体内模型。
Infect Dis Model. 2024 Feb 7;9(2):458-473. doi: 10.1016/j.idm.2024.02.004. eCollection 2024 Jun.
5
Characterization of Dengue Virus Serotype 2 Cosmopolitan Genotype Circulating in Colombia.哥伦比亚流行的登革热病毒血清型 2 世界性基因型的特征。
Am J Trop Med Hyg. 2023 Oct 9;109(6):1298-1302. doi: 10.4269/ajtmh.23-0375. Print 2023 Dec 6.
6
Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement.登革病毒中和抗体:目标、交叉反应性和抗体依赖性增强的综述。
Front Immunol. 2023 Jun 2;14:1200195. doi: 10.3389/fimmu.2023.1200195. eCollection 2023.
7
Mathematical models for dengue fever epidemiology: A 10-year systematic review.登革热流行病学的数学模型:一项 10 年系统性回顾。
Phys Life Rev. 2022 Mar;40:65-92. doi: 10.1016/j.plrev.2022.02.001. Epub 2022 Feb 15.
IgG Fc 受体在抗体依赖的增强中的作用。
Nat Rev Immunol. 2020 Oct;20(10):633-643. doi: 10.1038/s41577-020-00410-0. Epub 2020 Aug 11.
4
Ethics of a partially effective dengue vaccine: Lessons from the Philippines.部分有效的登革热疫苗的伦理问题:来自菲律宾的教训。
Vaccine. 2020 Jul 31;38(35):5572-5576. doi: 10.1016/j.vaccine.2020.06.079. Epub 2020 Jul 10.
5
Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.四价登革热疫苗在 4-16 岁健康儿童中的疗效:一项随机、安慰剂对照、3 期临床试验。
Lancet. 2020 May 2;395(10234):1423-1433. doi: 10.1016/S0140-6736(20)30414-1. Epub 2020 Mar 17.
6
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.四价登革热疫苗在健康儿童和青少年中的功效。
N Engl J Med. 2019 Nov 21;381(21):2009-2019. doi: 10.1056/NEJMoa1903869. Epub 2019 Nov 6.
7
Adaptive immune responses to primary and secondary dengue virus infections.初次和再次登革热病毒感染的适应性免疫反应。
Nat Rev Immunol. 2019 Apr;19(4):218-230. doi: 10.1038/s41577-019-0123-x.
8
Dengue vaccination: a more ethical approach is needed.登革热疫苗接种:需要一种更符合伦理的方法。
Lancet. 2018 May 5;391(10132):1769-1770. doi: 10.1016/S0140-6736(18)30865-1.
9
Dengvaxia: age as surrogate for serostatus.登革热疫苗(Dengvaxia):以年龄作为血清学状态的替代指标。
Lancet Infect Dis. 2018 Mar;18(3):245. doi: 10.1016/S1473-3099(17)30752-1. Epub 2017 Dec 21.
10
Dengvaxia Efficacy Dependency on Serostatus: A Closer Look at More Recent Data.登革热疫苗(Dengvaxia)效力对血清状态的依赖性:深入研究最新数据
Clin Infect Dis. 2018 Feb 1;66(4):641-642. doi: 10.1093/cid/cix882.